Skip to main content
Gary Gordon, MD, Radiology, Kensington, MD

GaryHartGordonMD

Radiology Kensington, MD

Nuclear Medicine

Physician

Are you Dr. Gordon?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 52 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    10810 Connecticut Ave
    Kaiser Permanente Kensington Medical Center
    Kensington, MD 20895
    Phone+1 301-929-7100

Summary

  • Dr. Gary Gordon, MD is a board certified radiologist in Kensington, Maryland. He is currently licensed to practice medicine in Maryland, Georgia, and District of Columbia.

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Radiology-Diagnostic, 1985 - 1986
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Nuclear Medicine, 1984 - 1985
  • Rutgers Health/Cooperman Barnabas Medical Center
    Rutgers Health/Cooperman Barnabas Medical CenterResidency, Radiology-Diagnostic, 1981 - 1984
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1981

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1983 - Present
  • DC State Medical License
    DC State Medical License 1988 - 2027
  • MD State Medical License
    MD State Medical License 1988 - 2026
  • VA State Medical License
    VA State Medical License 1987 - 2026
  • GA State Medical License
    GA State Medical License 2021 - 2024
  • PA State Medical License
    PA State Medical License 1985 - 1988
  • American Board of Radiology Diagnostic Radiology

Press Mentions

  • Ayala Pharmaceuticals Presents Encouraging Preliminary Safety and Efficacy Data in Patients with Recurrent/Metastatic Adenoid Cystic Carcinoma with Progressing Disease and Notch Activating Mutations from Ongoing Phase 2 Clinical Trial at ESMO
    Ayala Pharmaceuticals Presents Encouraging Preliminary Safety and Efficacy Data in Patients with Recurrent/Metastatic Adenoid Cystic Carcinoma with Progressing Disease and Notch Activating Mutations from Ongoing Phase 2 Clinical Trial at ESMOSeptember 30th, 2019